Lot No.a | Epitope specific antigenicity (Relative IC50) | |||
---|---|---|---|---|
 | H16.V5 | H16.E70 | H263.A2 | H16.J4 |
pre-D/R | Â | Â | Â | Â |
C1 | 0.54 | 0.30 | 0.53 | 6.73 |
C2(pre-) | 0.51 | 0.31 | 0.51 | 5.51 |
C3(pre-) | 0.48 | 0.27 | 0.46 | 5.24 |
Ave. (n = 3) | 0.51 ± 0.03 | 0.29 ± 0.02 | 0.50 ± 0.03 | 5.83 ± 0.80 |
post-D/R | Â | Â | Â | Â |
C2 | 1.17 | 1.33 | 1.11 | 0.43 |
C3 | 0.89 | 0.94 | 0.95 | 1.05 |
C4 | 0.97 | 0.83 | 1.00 | 0.94 |
C5b | 1.00 | 1.00 | 1.00 | 1.00 |
K1 | 1.01 | 1.08 | 0.88 | 0.91 |
K2 | 0.76 | 0.83 | 0.82 | 0.73 |
K3 | 0.93 | 0.95 | 0.92 | 0.70 |
K4 | 0.94 | 0.95 | 0.92 | 0.88 |
Ave. (n = 8) | 0.96 ± 0.10 | 0.99 ± 0.07 | 0.95 ± 0.06 | 0.83 ± 0.10 |